Outcomes of Patients with Clinical T1 Grade 3 Urothelial Cell Bladder Carcinoma Treated with Radical Cystectomy

Urology

Volumn 71, Issue 2, 2008, Pages 302-307

  Gupta, Amit ^a   Lotan, Yair ^a   Bastian, Patrick J ^b   Palapattu, Ganesh S ^b   Karakiewicz, Pierre I ^c   Raj, Ganesh V ^a   Schoenberg, Mark P ^d   Lerner, Seth P ^d   Sagalowsky, Arthur I ^a   Shariat, Shahrokh F ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; CANCER GRADING; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; UNITED STATES; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 39549103438     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.10.041     Document Type: Article

References (22)

1. Amling C.L., Thrasher J.B., Frazier H.A., et al. Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J Urol 151 (1994) 31-35 discussion 35-36
2. Cheng L., Neumann R.M., Weaver A.L., et al. Grading and staging of bladder carcinoma in transurethral resection specimens: correlation with 105 matched cystectomy specimens. Am J Clin Pathol 113 (2000) 275-279
3. Freeman J.A., Esrig D., Stein J.P., et al. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 76 (1995) 833-839
4. Masood S., Sriprasad S., Palmer J.H., et al. T1G3 bladder cancer: indications for early cystectomy. Int Urol Nephrol 36 (2004) 41-44
5. Wiesner C., Pfitzenmaier J., Faldum A., et al. Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy. BJU Int 95 (2005) 301-305
6. Dutta S.C., Smith Jr. J.A., Shappell S.B., et al. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol 166 (2001) 490-493
7. Huguet J., Crego M., Sabate S., et al. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor. Eur Urol 48 (2005) 53-59 discussion 59
8. Ficarra V., Dalpiaz O., Alrabi N., et al. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int 95 (2005) 786-790
9. Herr H.W. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162 (1999) 74-76
10. Cookson M.S., Herr H.W., Zhang Z.F., et al. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 158 (1997) 62-67
11. Stein J.P. Indications for early cystectomy. Urology 62 (2003) 591-595
12. Thalmann G.N., Markwalder R., Shahin O., et al. Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy?. J Urol 172 (2004) 70-75
13. Van Der Meijden A., Sylvester R., Collette L., et al. The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of 5 European Organization for Research and Treatment of Cancer Trials. J Urol 164 (2000) 1533-1537
14. Lee C.T., Madii R., Daignault S., et al. Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. J Urol 175 (2006) 1262-1267 discussion 1267
15. Sanchez-Ortiz R.F., Huang W.C., Mick R., et al. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 169 (2003) 110-115 discussion 115
16. Bianco Jr. F.J., Justa D., Grignon D.J., et al. Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy. Urol Oncol 22 (2004) 290-294
17. Orsola A., Trias I., Raventos C.X., et al. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients. Eur Urol 48 (2005) 231-238 discussion 238
18. Sylvester R.J., van der Meijden A.P., Oosterlinck W., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49 (2006) 465-466 discussion 475-477
19. Grimm M.O., Steinhoff C., Simon X., et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 170 (2003) 433-437
20. Raj G.V., Herr H., Serio A.M., et al. Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer. J Urol 177 (2007) 1283-1286 discussion 1286
21. Cheng L., Neumann R.M., Weaver A.L., et al. Predicting cancer progression in patients with stage T1 bladder carcinoma. J Clin Oncol 17 (1999) 3182-3187
22. Gattegno B. T1G3 bladder cancer: conservative management or cystectomy?. Eur Urol 45 (2004) 399-400